oral ghk-cu bioavailability ghk cu The Human Tripeptide in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health ghk-cu bioavailability Repost from – oral ghk cu ghk-cu via

(2015), BioMed Research International 2015:648108, PubMed 26236730 Statistics from research literature Discovered by Loren Pickart in human blood plasma in 1973 , as a factor extending the longevity of cultured liver cells The smallest peptide with documented pharmacological activity: 3 amino acids (Gly-His-Lys) + one Cu ion Molecular weight: 402 Da EU cosmetic INCI name: Copper Tripeptide-1 (registered in EU Commission CosIng database) Gene expression modulation: 4 000 human genes (Connectivity Map dataset, Pickart 2015) Plasma level in healthy humans declines from ~200 ng/mL at age 20 to ~80 ng/mL at age 60 (62 % decrease) Most-studied bioactivities: fibroblast proliferation , type I/III collagen synthesis , antioxidant activity (SOD upregulation) Reference sources (PubMed) Pickart L., Vasquez-Soltero JM., Margolina A

BMAC has been show to use the bodys own healing properties to speed up healing within a joint or bone without surgery

J Physiol Paris 93:505512 Sikiric P, Separovic J, Buljat G et al (2000) The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolts test and chronic unpredictable stress in rats

Follow these steps exactly